Medicare beneficiaries are expected to see lower Part B premiums in 2023 due to the lower price of Alzheimer’s drug, Aduholm.
Today, Department of Health and Human Services Secretary Xavier Becerra said 2002 Medicare Part B premiums should be adjusted downward due to the drug manufacturer reducing the price of Aduholm from $56,000 per year to $26,200 per year.
